Total Non-Current Liabilities
€629.30M
Quarterly · Period ending: · EUR

BNTX Total Non-Current Liabilities
What is total non-current liabilities?
Long-term obligations due beyond one year.
BNTX total non-current liabilities history
Annual fiscal periods · EUR. Dates are reporting period ends; fiscal years can differ from calendar years. Change compares each value with the period before it.
| Period ending | Total Non-Current Liabilities (EUR) | Change |
|---|---|---|
| 621,835,230 | +4.44% | |
| 595,400,000 | −13.70% | |
| 689,900,000 | +152.80% | |
| 272,900,000 | −40.09% | |
| 455,500,000 | +33.66% | |
| 340,800,000 | +105.29% | |
| 166,013,000 | −36.12% | |
| 259,865,000 | −1.71% | |
| 264,375,000 | −12.30% | |
| 301,465,000 | — |
Frequently asked questions: BNTX total non-current liabilities
What is BioNTech SE (BNTX)'s current total non-current liabilities?
BioNTech SE (BNTX)'s latest reported total non-current liabilities (Quarterly) is €629.30M as of Sep 30, 2026. Long-term obligations due beyond one year.
How much historical total non-current liabilities data is available for BNTX?
Stock Alarm Pro provides 10 dated annual fiscal periods observations for BioNTech SE (BNTX)'s total non-current liabilities, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.
How can I compare BNTX's total non-current liabilities to peers or set an alert?
You can open BNTX's total non-current liabilities in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on BNTX delivered by push, email, or phone call.
Explore More
Explore 130+ historical metrics & ratios
Compare BNTX and MRNA side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance